These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30587846)

  • 1. Compound heterozygous variants in MOGS inducing congenital disorders of glycosylation (CDG) IIb.
    Li M; Xu Y; Wang Y; Yang XA; Jin D
    J Hum Genet; 2019 Mar; 64(3):265-268. PubMed ID: 30587846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
    Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
    Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of novel mutations in MOGS in a Chinese patient with infantile spams.
    Peiwei Zhao ; Peng X; Luo S; Huang Y; Tan L; Shao J; He X
    Neurogenetics; 2020 Apr; 21(2):97-104. PubMed ID: 31925597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.
    Kane MS; Davids M; Adams C; Wolfe LA; Cheung HW; Gropman A; Huang Y; ; Ng BG; Freeze HH; Adams DR; Gahl WA; Boerkoel CF
    Am J Hum Genet; 2016 Feb; 98(2):339-46. PubMed ID: 26805780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation, hypogammaglobulinemia, and resistance to viral infections.
    Sadat MA; Moir S; Chun TW; Lusso P; Kaplan G; Wolfe L; Memoli MJ; He M; Vega H; Kim LJY; Huang Y; Hussein N; Nievas E; Mitchell R; Garofalo M; Louie A; Ireland DC; Grunes C; Cimbro R; Patel V; Holzapfel G; Salahuddin D; Bristol T; Adams D; Marciano BE; Hegde M; Li Y; Calvo KR; Stoddard J; Justement JS; Jacques J; Priel DAL; Murray D; Sun P; Kuhns DB; Boerkoel CF; Chiorini JA; Di Pasquale G; Verthelyi D; Rosenzweig SD
    N Engl J Med; 2014 Apr; 370(17):1615-1625. PubMed ID: 24716661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic dysmorphic features in congenital disorders of glycosylation type IIb.
    Kim YM; Seo GH; Jung E; Jang JH; Kim SZ; Lee BH
    J Hum Genet; 2018 Mar; 63(3):383-386. PubMed ID: 29235540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannosyl-oligosaccharide glucosidase - congenital disorder of glycosylation: A patient with novel variants.
    Ota M; Miyahara J; Itano A; Sugiura H; Ohki S
    Pediatr Int; 2020 Mar; 62(3):417-418. PubMed ID: 32246563
    [No Abstract]   [Full Text] [Related]  

  • 8. Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA : Report of a new patient and review of the literature.
    Teutonico F; Volpe C; Proto A; Costi I; Cavallari U; Doneda P; Iascone M; Sturiale L; Barone R; Martinelli S; Vignoli A
    Neurogenetics; 2024 Jul; 25(3):281-286. PubMed ID: 38498292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of glucosidase I-mediated glycoprotein deglucosylation results in a sick phenotype in fission yeasts: Model for the human MOGS-CDG disorder.
    Gallo GL; Valko A; Aramburu SI; Etchegaray E; Völker C; Parodi AJ; D'Alessio C
    J Biol Chem; 2018 Dec; 293(52):19957-19973. PubMed ID: 30389790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient.
    Lo Barco T; Osanni E; Bordugo A; Rodella G; Iascone M; Tenconi R; Barone R; Dalla Bernardina B; Cantalupo G
    Am J Med Genet A; 2021 Jan; 185(1):219-222. PubMed ID: 33058492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygous variants of the COG6 gene in a Chinese patient with deficiency of subunit 6 of the conserved oligomeric Golgi complex (COG6-CDG).
    Li G; Xu Y; Hu X; Li N; Yao R; Yu T; Wang X; Guo W; Wang J
    Eur J Med Genet; 2019 Jan; 62(1):44-46. PubMed ID: 29709711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum N-glycomics of a novel CDG-IIb patient reveals aberrant IgG glycosylation.
    Beimdiek J; Hennig R; Burock R; Puk O; Biskup S; Rapp E; Lesinski-Schiedat A; Buettner FFR; Das AM
    Glycobiology; 2022 Apr; 32(5):380-390. PubMed ID: 35137040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDG-Id in two siblings with partially different phenotypes.
    Kranz C; Sun L; Eklund EA; Krasnewich D; Casey JR; Freeze HH
    Am J Med Genet A; 2007 Jul; 143A(13):1414-20. PubMed ID: 17551933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOGS-CDG: Quantitative analysis of the diagnostic Glc
    Post MA; de Wit I; Zijlstra FSM; Engelke UFH; van Rooij A; Christodoulou J; Tan TY; Le Fevre A; Jin D; Yaplito-Lee J; Lee BH; Low KJ; Mallick AA; Õunap K; Pitt J; Reardon W; Vals MA; Wortmann SB; Wessels HJCT; Bärenfänger M; van Karnebeek CDM; Lefeber DJ
    J Inherit Metab Dis; 2023 Mar; 46(2):313-325. PubMed ID: 36651519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RFT1-CDG in adult siblings with novel mutations.
    Ondruskova N; Vesela K; Hansikova H; Magner M; Zeman J; Honzik T
    Mol Genet Metab; 2012 Dec; 107(4):760-2. PubMed ID: 23111317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC35A2-CDG: novel variants with two ends of the spectrum.
    Kasapkara ÇS; Ceylan AC; Özyürek H; Karakaya Molla G; Civelek Ürey B; Kıreker Köylü O; Küçükçongar Yavaş A; Sönmez FM
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1185-1189. PubMed ID: 34161696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ALG12 variants and hydronephrosis in siblings with impaired N-glycosylation.
    Hiraide T; Wada Y; Matsubayashi T; Kadoya M; Masunaga Y; Ohkubo Y; Nakashima M; Okamoto N; Ogata T; Saitsu H
    Brain Dev; 2021 Oct; 43(9):945-951. PubMed ID: 34092405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
    Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
    Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype.
    Iqbal Z; Shahzad M; Vissers LE; van Scherpenzeel M; Gilissen C; Razzaq A; Zahoor MY; Khan SN; Kleefstra T; Veltman JA; de Brouwer AP; Lefeber DJ; van Bokhoven H; Riazuddin S
    Eur J Hum Genet; 2013 Aug; 21(8):844-9. PubMed ID: 23249953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
    Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
    Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.